Danielle Remington
Optometrist · Tempe, AZNPI 1780098806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $37.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$732
- AbbVie$678
- Oyster Point Pharma, Inc.$591
- Bausch & Lomb Americas Inc.$552
- Rxsight Inc$501
- Lumenis BE Inc$438
- plus $3K from 21 others
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$2K
What the payments were for
- Speaking & faculty fees$260%
- Food & beverage$6,562100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 19 | $732 |
| AbbVie(2 entities) | 25 | $678 |
| Oyster Point Pharma, Inc. | 16 | $591 |
| Bausch & Lomb Americas Inc. | 17 | $552 |
| Rxsight Inc | 9 | $501 |
| Lumenis BE Inc | 1 | $438 |
| Kala Pharmaceuticals, Inc. | 18 | $416 |
| Tarsus Pharmaceuticals, Inc. | 14 | $403 |
| Aerie Pharmaceuticals, Inc. | 4 | $331 |
| Glaukos Corporation | 4 | $299 |
| Shire North American Group Inc | 6 | $265 |
| Novartis | 12 | $252 |
| Apellis Pharmaceuticals, Inc. | 3 | $191 |
| LKC Technologies, Inc. | 2 | $144 |
| Johnson & Johnson Vision Care, Inc. | 2 | $137 |
| Coopervision Inc. | 1 | $90 |
| Dompe US, Inc. | 3 | $80 |
| Sun Pharmaceutical Industries Inc. | 3 | $72 |
| Sight Sciences, Inc. | 2 | $69 |
| Harrow Eye, LLC | 2 | $67 |
| Amgen | 3 | $58 |
| Thea Pharma Inc. | 3 | $51 |
| Alcon | 2 | $48 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $45 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Eyevance Pharmaceuticals LLC | 1 | $20 |
| Katena Products, Inc. (dba Corza Medical) | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- optilight$438
- TYRVAYA$301
- RXSIGHT CONTACT LENS$277
- RXSIGHT INJECTOR CARTRIDGE$277
- RXSIGHT INJECTOR HANDPIECE$277
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$277
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$277
- INVELTYS$250
- EYSUVIS$250
- Rhopressa$224
- Rocklatan$224
- RESTASIS$224
- iDose$140
- Syfovre$125
- XDEMVY$125
- VYZULTA$123
- XIIDRA$122
- MIEBO$117
- Acuvue$116
How this compares
$6,587 in reported general payments places this provider in the 95th percentile of 1,134 optometrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 143 | $157,510 |
| XdemvyLotilaner | 44 | $83,224 |
| LumiganBimatoprost | 89 | $60,632 |
| XiidraLifitegrast | 50 | $53,916 |
| TyrvayaVarenicline Tartrate | 67 | $52,234 |
| MieboPerfluorohexyloctane/Pf | 48 | $37,863 |
| Cyclosporine | 47 | $24,806 |
| RhopressaNetarsudil Mesylate | 18 | $12,248 |
| RocklatanNetarsudil Mesylat/Latanoprost | 13 | $6,188 |
| Alphagan PBrimonidine Tartrate | 12 | $4,854 |
| Prednisolone Acetate | 64 | $3,140 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 12 | $2,842 |
| Latanoprost | 183 | $2,414 |
| Timolol Maleate | 78 | $949 |
| Brimonidine Tartrate | 46 | $768 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Alphagan P | $678 | $222,996244 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $552 | $91,78098 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $403 | $83,22444 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $591 | $52,23467 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $331 | $18,43731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,134 optometrist providers in Arizona.
Other optometrist in Tempe
- John ChrisagisTempe$10K
- Marc BloomensteinScottsdale$1.4M
- Stephanie WooLake Havasu City$538K
- Jashpal RajasansiGilbert$104K
- Jamie KuhnGlendale$37K
- Tania SobchukLake Havasu City$32K
- Stephen CohenScottsdale$32K
- Andrew ZagelbaumScottsdale$25K
- Linda TrinhPeoria$22K
- Jason BaileyGilbert$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.